Simulect torrino

Indice Simulect è indicato per la profilassi del rigetto acuto in pazienti adulti e pediatrici (1-17 anni) sottoposti a trapianto renale allogenico de novo (vedere paragrafo 4.2). Deve essere usato in associazione ad un trattamento immunosoppressivo a base di ciclosporina in microemulsione e … Visa mer Indice Ogni flaconcino contiene 20 mg di basiliximab*. Un ml di soluzione ricostituita contiene 4 mg di basiliximab. anticorpo monoclonale chimerico murino/umano ricombinante diretto contro la catena  del … Visa mer Indice Tracciabilità Al fine di migliorare la tracciabilità dei medicinali biologici, il nome e il numero di lotto del medicinale somministrato devono … Visa mer Indice Simulect deve essere prescritto solo da medici con esperienza nell’utilizzo di terapie immunosoppressive conseguenti a … Visa mer Indice Ipersensiblità al principio attivo o ad uno qualsiasi degli eccipienti elencati al paragrafo 6.1. Gravidanzae allattamento (vedere paragrafo 4.6). Visa mer WebbSimulect is a sterile freeze-dried powder for intravenous infusion or injection after reconstitution with the solvent, water for injection. Simulect is marketed in the 20 mg …

Simulect - fass.se

Webb3 apr. 2024 · Simulect ® (basiliximab) is a chimeric (murine/human) monoclonal antibody (IgG 1к ), produced by recombinant DNA technology, that functions as an immunosuppressive agent, specifically binding to and blocking the interleukin-2 receptor α-chain (IL-2Rα, also known as CD25 antigen) on the surface of activated T-lymphocytes. WebbSimulect should be administered under qualified medical supervision. Simulect must not be administered unless it is absolutely certain that the patient will receive the graft and … incompatibility\u0027s y2 https://nicoleandcompanyonline.com

Package leaflet: Information for the user Simulect basiliximab

Webb10 maj 2012 · It will be conducted in low risk de novo adult renal transplant recipients until 12 weeks post-transplant, receiving either a cumulative dose of 40 or 80 mg of Simulect® in combination with Neoral®, or a cumulative dose of 80 mg of Simulect® in a calcineurin inhibitor free immunosuppressant therapy. Study Design Go to WebbSimulect ska endast ordineras av läkare med erfarenhet av immunsuppressiv behandling vid organtransplantation. Simulect ska administreras under kvalificerat medicinskt … WebbSimulect Injection is a class of medications called immunosuppressants. It is used to prevent immediate transplant rejection (attack of the transplanted organ by the immune … incompatibility\u0027s y7

Simulect : Uses, Side Effects, Interactions, Dosage / Pillintrip

Category:Simulect Injection: View Uses, Side Effects, Price and Substitutes

Tags:Simulect torrino

Simulect torrino

BILAGA I PRODUKTRESUMÉ - European Medicines Agency

Webb8 apr. 2024 · Simulect är indicerat som profylax mot akut avstötningsreaktion efter allogen de novo transplantation av njure hos vuxna patienter och barn (1-17 år) (se avsnitt Dosering). Det ska användas tillsammans med ciklosporin mikroemulsion och kortikosteroidbaserad immunsuppression hos patienter med panelreaktiva Webb4 okt. 2024 · Simulect is used with other medications to prevent organ rejection after a kidney transplant. This medicine weakens your immune system to prevent your body …

Simulect torrino

Did you know?

Webborgantransplantation. Simulect ska administreras under kvalificerat medicinskt överinseende. Simulect får endast ges om det är absolut säkert att patienten ska transplanteras och samtidigt få immunsuppressiv behandling. Simulect ska användas samtidigt med ciklosporin mikroemulsion och kortikosteroidbaserad immunsuppression. Webb15 okt. 2024 · At transplantation time all patients received induction therapy, consisted of either basiliximab (Simulect; Novartis Pharmaceuticals Corp., East Hanover, NJ) or rabbit anti-thymocyte globulin (rATG; Thymoglobulin; Genzyme, Cambridge, MA) in association with steroids, according to donor (standard or ECD) and recipient characteristics (i.e. …

Webb27 juli 2015 · Simulect (basiliximab) Preventing rejection of kidney transplants (in combination with ciclosporin and corticosteroids). Basiliximab is given by injection or infusion (drip) into a vein. Only two... Webb27 feb. 2024 · Simulect is used in adults and children aged over one year, to prevent the body from rejecting a newly transplanted kidney. Simulect is used in combination with …

Webb29 sep. 2011 · It will be conducted in low risk de novo adult renal transplant recipients until 12 weeks post-transplant, receiving either a cumulative dose of 40 or 80 mg of Simulect® in combination with Neoral®, or a cumulative dose of 80 mg of Simulect® in a calcineurin inhibitor free immunosuppressant therapy.. Clinical Trials Registry. ICH GCP. English Webb19 juli 2024 · Simulect® (basiliximab) is a chimeric (murine/human) monoclonal antibody ( IgG 1K ), produced by recombinant DNA technology, that functions as an immunosuppressive agent, specifically binding to and blocking the interleukin-2 receptor α-chain (IL-2Rα, also known as CD25 antigen) on the surface of activated T-lymphocytes.

WebbSimulect tillhör en grupp läkemedel som benämns immunsuppressiva läkemedel. Det ges till vuxna, ungdomar och barn som njurtransplanteras och ligger på sjukhus. …

WebbSimulect kan ges till äldre patienter, men tillgänglig information är begränsad. Din läkare kan komma att diskutera detta med dig innan du får Simulect. Barn och ungdomar (1–17 år) Simulect kan ges till barn och ungdomar. Dosen till barn som väger under 35 kg är lägre än den som vanligen ges till vuxna. incompatibility\u0027s ycWebb10 aug. 2024 · Simulect 10 mg injektio- tai infuusiokuiva-aine ja liuotin, liuosta varten. basiliksimabi. Yleisiä ohjeita. Lue tämä pakkausseloste huolellisesti, ennen kuin sinulle annetaan tätä lääkettä, sillä se sisältää sinulle tärkeitä tietoja. Säilytä tämä pakkausseloste. incompatibility\u0027s y8WebbSimulect® (Basiliximab) – Individual Exchange Medical Benefit Drug Policy Author: UnitedHealthcare Subject: Effective Date: 01.01.2024 This policy addresses the use of Simulect® \(basiliximab\) for the treatment of prophylaxis of acute organ rejection. Applicable Procedure Code: J0480. Created Date: 20241026154945Z incompatibility\u0027s yiWebb19 juli 2024 · Simulect (basiliximab) is an immunosuppressant drug known as a monoclonal antibody used with other medications to prevent organ rejection after a … incompatibility\u0027s yfWebb4 okt. 2024 · Simulect is used with other medications to prevent organ rejection after a kidney transplant. This medicine weakens your immune system to prevent your body from "rejecting" the transplanted kidney. Simulect may also be used for purposes not listed in this medication guide. Warnings You may get infections or bleed more easily. incompatibility\u0027s yeWebbIt has been shown that an induction therapy with the monoclonal anti-interleukin-2 receptor antibody basiliximab (Simulect) is capable to reduce the incidence of acute graft rejection in adult and pediatric liver transplantation (Ltx). However, data on long-term results using basiliximab in children post-Ltx are still pending. incompatibility\u0027s ydWebb11 juni 2014 · Simulect Versus ATG in Sensitized Renal Transplant Patient (SATIR) October 24, 2024 updated by: University Hospital, Toulouse. Prospective, Multicenter, Randomized, Evaluating Two Induction Therapies With Simulect® Versus ATG® Fresenius Associated With Tacrolimus and Myfortic® in the Prevention of Treatment Failure, in Sensitized ... incompatibility\u0027s yg